Status of water-soluble vitamins and neurological disorders in dialysis patients

Cover Page

Cite item

Full Text

Abstract

The deficit of vitamins in patients receiving the long-term hemodialysis is discussed in the modern literature. Vitamin deficiency in a dialysis patient can be explained by the peculiarity of the diet recommendations, the need to take a number of medications, impaired absorption of vitamins in the digestive tract, poor appetite, uremic anorexia, depression, limited ability to buy and cook food, as well as losses of vitamins during the procedure of program hemodialysis. An analytical review of current (2011 and later) publications containing a comprehensive analysis of data on the status of water-soluble vitamins and its role in the development of neurological disorders in dialysis patients is provided. There is a high risk of deficiency of various water soluble vitamins and neurological disorders, such as vitamin B1 deficiency and thiamine deficiency encephalopathy and polyneuropathy, vitamin B6 deficiency and pyridoxine deficiency polyneuropathy, folic acid metabolism disorders, as well as vitamin B12 and the development of hyperhomocysteinemia, cognitive and depressive disorders, strokes, restless legs syndrome and dialysis polyneuropathy among the patients with end-stage chronic kidney disease and program hemodialysis. Vitamin C deficiency and the development of severe asthenic syndrome with insomnia and depression are described in dialysis patients. It seems necessary to revise the traditional nutritional approaches to the dialysis patients based on the analysis of the literature. Special attention is paid to the possible addition of such water-soluble vitamins as B1, B6, B9, B12 and C. Timely diagnosis of vitamin deficiency conditions and neurological disorders in patients on program hemodialysis, the development of methods for their correction and their introduction into clinical practice would improve the life expectancy and quality of life of dialysis patients.

About the authors

Aleksej E. Khrulev

Privolzhsky Research Medical University

Author for correspondence.
Email: alexey_khrulev@mail.ru
ORCID iD: 0000-0003-0169-3956
SPIN-code: 1051-9769
Scopus Author ID: 57210284114
ResearcherId: AAA-6833-2019
http://employee.pimunn.ru/id766/details

кандидат медицинских наук, доцент кафедры нервных болезней

Russian Federation, 10/1 Minin and Pozharsky Square, N. Novgorod 603950

Alina N. Baykina

Privolzhsky Research Medical University

Email: baykina.alina@mail.ru
ORCID iD: 0000-0002-6671-1943
ResearcherId: AAE-5244-2019

клинический ординатор кафедры нервных болезней

Russian Federation, 10/1 Minin and Pozharsky Square, N. Novgorod 603950

Natal’ya A. Shiyanova

Privolzhsky Research Medical University

Email: shiyanova1997@mail.ru
ORCID iD: 0000-0001-8346-9354

клинический ординатор кафедры нервных болезней

Russian Federation, 10/1 Minin and Pozharsky Square, N. Novgorod 603950

Anna Yu. Sirotkina

Privolzhsky Research Medical University

Email: alexey_khrulev@mail.ru
ORCID iD: 0000-0003-1550-3973
SPIN-code: 1950-8998
ResearcherId: AAE-5265-2019

клинический ординатор кафедры нервных болезней

Russian Federation, 10/1 Minin and Pozharsky Square, N. Novgorod 603950

Ol’ga Yu. Salokhina

National Research Nizhny Novgorod State University named after N.I. Lobachevsky

Email: salohina-olya@mail.ru
ORCID iD: 0000-0002-3129-4887
ResearcherId: AAE-4591-2019

аспирант института биологии и медицины

Russian Federation, Gagarin Ave., 23, Nizhny Novgorod, 603950

Vera N. Grigorieva

Privolzhsky Research Medical University

Email: vrgr@yandex.ru
ORCID iD: 0000-0002-6256-3429
SPIN-code: 3412-5653
http://employee.pimunn.ru/departments/54/employees

доктор медицинских наук, профессор, зав.кафедрой нервных болезней ФГБОУ ВО «ПИМУ» Минздрава РФ

Russian Federation, 10/1 Minin and Pozharsky Square, N. Novgorod 603950

References

  1. Boussekey N., Capron B., Delannoy P.Y. et al. Survival in critically ill patients with acute kidney injury treated with early hemodiafiltration. Int. J. Artif. Organs. 2012; 35 (12): 1039–1046. doi: 10.5301/ijao.5000133.
  2. Ene-Iordache B., Perico N., Bikbov B. et al. Chronic kidney disease and cardiovascular risk in six regions of the world (ISN-KDDC): a cross-sectional study. Lancet Glob. Health. 2016; 4 (5): e307–319. doi: 10.1016/S2214-109X(16)00071-1.
  3. Chillon J.-M., Massy Z.A., Stengel B. Neurological complications in chronic kidney disease patients. Nephrol. Dial. Transplant. 2016; 31 (10): 1606–1614. doi: 10.1093/ndt/gfv315.
  4. Clase C.M., Ki V., Holden R.M. Water-soluble vitamins in people with low glomerular filtration rate or on dialysis: a review. Semin. Dial. 2013; 26 (5): 546–567. doi: 10.1111/sdi.12099.
  5. Chazot C., Jean G., Kopple J.D. Can outcomes be improved in dialysis patients by optimizing trace mineral, micronutrient, and antioxidant status? The impact of vitamins and their supplementation. Semin. Dial. 2016; 29 (1): 39–48. doi: 10.1111/sdi.12443.
  6. Geller M., Oliveira L., Nigri R. et al. Vitamins for neuropathy and neuropathic pain. Vitamins and Minerals. 2017; 6: 2. doi: 10.4172/2376-1318.1000161.
  7. Frank L.L. Tiamin in clinical practice. J. Parenter. Enteral. Nutr. 2015; 39 (5): 503–520. doi: 10.1177/0148607114565245.
  8. Zhang Q., Zhang Y., Diamond S. et al. Janus kinase 2 inhibitor fedratinib inhibits thiamine uptake: a putative mechanism of the onset of Wernicke’s encephalopathy. Drug Metab. Dispos. 2014; 42 (10): 1656–1662. doi: 10.1124/dmd.114.058883.
  9. Altun I., Kurutas E.B. Vitamin B complex and vitamin B12 levels and a peripheral nerve injury. Neural Regen. Res. 2016; 11 (5): 842–845. doi: 10.4103/1673-5374.177150.
  10. Maladkar M., Tekchandani C., Dave U. Post-marketing surveillance of fixed dose combination of methylcobalamine, alpha lipoic acid, folic acid, biotin, benfotiamine & vitamin B6-nutripathy for the management of peripheral neuropathy. J. Diabetes Mellitus. 2014; 4: 124–132. doi: 10.4236/jdm.2014.42019.
  11. Jankowska M., Rutkowski B., Debska-Slizien A. Vitamins and microelement bioavailability in different stages of chronic kidney disease. Nutrients. 2017; 9 (3): 282. doi: 10.3390/nu9030282.
  12. McGarvey C., Franconi C., Prentice D., Bynevelt M. Metformin-induced encephalopathy: the role of thiamine. Intern. Med. J. 2018; 48 (2): 194–197. doi: 10.1111/imj.13693.
  13. Kang Y.J., Bae E.J., Seo J.W. et al. Two additional cases of metformin-associated encephalopathy in patients with end stage renal disease undergoing haemodialysis. Hemodial. Int. 2013; 17 (1): 111–115. doi: 10.1111/j.1542-4758.2012.00698.x.
  14. Martín-del-Campo F., Batis-Ruvalcaba C., González-Espinoza L. et al. Dietary micronutrient intake in peritoneal dialysis patients: relationship with nutrition and inflammation status. Perit. Dial. Int. 2012; 32 (2): 183–191. doi: 10.3747/pdi.2010.00245.
  15. Kovesdy C.P., Kopple J.D., Kalantar-Zadeh K. Management of protein-energy wasting in non-dialysis-dependent chronic kidney disease: reconciling low protein intake with nutritional therapy. Am. J. Clin. Nutr. 2013; 97 (6): 1163–77. doi: 10.3945/ajcn.112.036418.
  16. Chen C.H., Yeh E.L., Chen C.C. et al. Vitamin B-6, independent of homocysteine, is a significant factor in relation to inflammatory responses for chronic kidney disease and hemodialysis patients. BioMed. Res. Intern. 2017; article ID 7367831: 8. DOI: https://doi.org/10.1155/2017/7367831.
  17. Soohoo M., Feng M., Obi Y. et al. Changes in markers of mineral and bone disorders and mortality in incident hemodialysis patients. Am. J. Nephrol. 2016; 43 (2): 85–96. doi: 10.1159/000444890.
  18. Chien S.C., Li S.Y., Chen Y.T. et al. Folic acid supplementation in end-stage renal disease patients reduces total mortality rate. J. Nephrol. 2013; 26 (6): 1097–1104. doi: 10.5301/jn.5000276.
  19. Ralapanawa D.M., Jayawickreme K.P., Ekanayake E.M., Jayalath W.A. B12 deficiency with neurological manifestations in the absence of anaemia. BMC Res. Notes. 2015; 18 (8): 458. doi: 10.1186/s13104-015-1437-9/
  20. Dangour A.D., Allen E., Clarke R. et al. Effects of vitamin B-12 supplementation on neurologic and cognitive function in older people: a randomized controlled trial. Am. J. Clin. Nutr. 2015; 102 (3): 639–647. doi: 10.3945/ajcn.115.110775.
  21. Franques J., Chiche L., Mathis S. Sensory neuronopathy revealing severe vitamin B12 deficiency in a patient with anorexia nervosa: An often-forgotten reversible cause. Nutrients. 2017; 9 (3): 281. doi: 10.3390/nu9030281.
  22. Spence J.D. Metabolic vitamin B12 deficiency: a missed opportunity to prevent dementia and stroke. Nutr. Res. 2016; 36 (2): 109–116. doi: 10.1016/j.nutres.2015.10.003.
  23. McCaddon A. Vitamin B12 in neurology and ageing; clinical and genetic aspects. Biochimie. 2013; 95 (5): 1066–1076. doi: 10.1016/j.biochi.2012.11.017.
  24. Harrison F.E. A critical review of Vitamin C for the prevention of age-related cognitive decline and Alzheimer’s disease. J. Alzheimers Dis. 2012; 29 (4): 711–726. doi: 10.3233/JAD-2012-111853.
  25. Green R. Indicators for assessing folate and vitamin B-12 status and for monitoring the efficacy of intervention strategies. Am. J. Clin. Nutr. 2011; 94 (2) (suppl.): 666–672. doi: 10.3945/ajcn.110.009613.
  26. Aparicio-Ugarriza R., Palacios G., Alder M., González-Gross M. A review of the cut-off points for the diagnosis of vitamin B12 deficiency in the general population. Clin. Chem. Lab. Med. 2015; 53 (8): 1149–1159. doi: 10.1515/cclm-2014-0784.
  27. Pastore A., Noce A., Giovamberardino G. et al. Homocysteine, cysteine, folate and vitamin B12 status in type 2 diabetic patients with chronic kidney disease. J. Nephrol. 2015; 28 (5): 571–576. doi: 10.1007/s40620-014-0126-4.
  28. Gade K., Blaschke S., Rodenbecka A. et al. Uremic restless legs syndrome (RLS) and sleep quality in patients with end-stage renal disease on hemodialysis: potential role of homocysteine and parathyroid hormone. Kidney Blood Press. Res. 2013; 37 (4–5): 458–463. doi: 10.1159/000355727.
  29. Gavriilaki E., Paschou E., Kalaitzoglou A. et al. B12 deficiency in chronic kidney disease: early recognition matters. Intern. Med. J. 2015; 45 (11): 1195–1196. doi: 10.1111/imj.12892.
  30. Babu M.M., Kiran M.R., Ravindra K. et al. Clinical manifestation and prevalence of peripheral neuropathy and nerve dysfunction in patients with chronic kidney disease. Int. J. Res. Med. Sci. 2015; 3 (2): 451–455. doi: 10.5455/2320-6012.ijrms20150213.
  31. Antoine J.C., Robert-Varvat F., Maisonobe T. et al. Testing the validity of a set of diagnostic criteria for sensory neuronopathies: a francophone collaborative study. J. Neurol. 2014; 261 (11): 2093–2100. doi: 10.1007/s00415-014-7423-7/.
  32. Kooshki A., Yazdi M.E., Moghaddam M.Y., Akbarzadeh R. Status of antioxidant and homocysteine-lowering vitamins related to cardiovascular diseases in hemodialysis patients. Electron. Physician. 2017; 9 (7): 4895–4898. doi: 10.19082/4895.
  33. Maniam R., Subramanian P., Singh S.K. et al. Preliminary study of an exercise programme for reducing fatigue and improving sleep among long-term haemodialysis patients. Singapore Med. J. 2014; 55 (9): 476–482. doi: 10.11622/smedj.2014119.
  34. Köse E., Turgutalp K., Kiykim A., Çelik F. The Association between feeding habits, nutritional parameters and quality of sleep in hemodialysis patients. Turkish Nephrol. 2014; 23 (1): 14–19. doi: 10.5262/tndt.2014.1001.04.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2020 Khrulev A.E., Baykina A.N., Shiyanova N.A., Sirotkina A.Y., Salokhina O.Y., Grigorieva V.N.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies